Enhancing Brain Lesions in a Renal Transplant Patient

The Neurohospitalist

Volumn 3, Issue 1, 2013, Pages 15-19

  Moscato, Margaret ^a   Restrepo, Lucas ^a   Boon Unge, Kritsanapol ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

brain neoplasms; central nervous system infection; posttransplant lymphoproliferative disorder (PTLD); primary central nervous system PTLD (PCNS PTLD); renal transplant

Indexed keywords

EID: 84992803611     PISSN: 19418744     EISSN: 19418752     Source Type: Journal    
DOI: 10.1177/1941874412459333     Document Type: Article

References (15)

1. Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR). OPTN / SRTR 2010 Annual Data Report. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; 2011. http://www.srtr.org/annual_reports/2010. Accessed April 18, 2012.
2. Morgans AK, Reshef R, Tsai DE. Posttransplant lymphoproliferative disorder following kidney transplant. Am J Kidney Dis. 2010; 55(1):168–180.
3. LaCasce A. Post-transplant lymphoproliferative disorders. Oncologist. 2006; 11(6):674–680.
4. Nabors L, Palmer C, Julian B, Przekwas A, Kew C. Isolated central nervous system posttransplant lymphoproliferative disorder treated with high-dose intravenous methotrexate. Am J Transplant. 2009; 9(5):1243–1248.
5. Swerdlow SH; International Agency for Research on Cancer, World Health Organization. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: International Agency for Research on Cancer; 2008.
6. Patchell R. Neurological complications of organ transplantation. Ann Neurol. 1994; 36(5):688–703.
7. Cavaliere R, Petroni G, Lopes MB, Schiff D. Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group Report. Cancer. 2010; 116(4):863–870.
8. Pickhardt P, Wippold F. Neuroimaging in posttransplantation lympoproliferative disorder. AJR Am J Roentgneol. 1999; 172(4):1117–1121.
9. Thanh P, O’Neill B, Kurtin P. Posttransplant primary CNS lymphoma. Neuro Oncol. 2000; 2(4):229–238.
10. Vaglio A, Manenti L, Mancini C, et alEBV-associated leukoencephalopathy with late onset of central nervous system lymphoma in a kidney transplant recipient. Am J Transplant. 2010; 10(4):947–951.
11. Hamadani M, Martin LK, Benson DM, Copelan EA, Devine SM, Hofmeister CC. Central nervous system post-transplant lymphoproliferative disorder despite negative serum and spinal fluid Epstein–Barr virus DNA PCR. Bone Marrow Transplant. 2007; 39(4):249–251.
12. Castellano-Sanchez A, Li S, Qian J, Lagoo A, Weir E, Brat D. Primary central nervous system posttransplant lymphoproliferative disorders. Am J Clin Pathol. 2004; 121(2):246–253.
13. Hess R. Routine Epstein-Barr virus diagnostics from the laboratory perspective: still challenging after 35 years. J Clin Microbiol. 2004; 42(8):3381–3387.
14. Tsai DE, Douglas L, Andreadis C, et alEBV PCR in the diagnosis and monitoring of posttransplant lymphoproliferative disorder: results of a two-arm prospective trial. Am J Transplant. 2008; 8(5):1016–1024.
15. Snanoudj R, Durrbach A, Leblond V, et alPrimary brain lymphomas after kidney transplantation: presentation and outcome. Transplantation. 2003; 76(6):930–937.